Precision medicine in diabetes: a Consensus Report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

2020/06/18 by Wendy K. Chung, Karel Erion, José C. Florez +15 · 203 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Diabetes Management and Research #Diabetes and associated disorders #Diabetes mellitus #Diabetology #Endocrinology #Family medicine #Intensive care medicine #Medicine #Pancreatic function and diabetes #Pathology #Precision medicine

paper · pdf · doi:10.1007/s00125-020-05181-w

published in Diabetologia 63(9), 1671-1693 (Springer Science+Business Media)

openalex publication_date 2020/06/18 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/05

Cited by

• A novel diabetes typology: towards precision diabetology from pathogenesis to treatment
• Diabetes precision medicine: plenty of potential, pitfalls and perils but not yet ready for prime time
• Type 2 diabetes subtypes for precision medicine: methodological challenges and alternative prediction-based approaches
• Spectrum of Phenotypes and Causes of Type 2 Diabetes in Children
• Subtypes of newly diagnosed type 2 diabetes and risk of complications: analysis of electronic health records in the USA
• Pharmacogenetics of novel glucose-lowering drugs. [europepmc]
• Type 1 diabetes mellitus: much progress, many opportunities. [europepmc]
• Perspectives on Precision Medicine Approaches to NAFLD Diagnosis and Management. [europepmc]
• SGLT-2i and Risk of Malignancy in Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials. [europepmc]
• The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). [europepmc]
• Physical Fitness and Cardiovascular Risk Factors in Novel Diabetes Subgroups. [europepmc]
• Pharmacogenomics and Personalized Medicine in Type 2 Diabetes Mellitus: Potential Implications for Clinical Practice. [europepmc]
• A novel diabetes typology: towards precision diabetology from pathogenesis to treatment. [europepmc]
• Spectrum of Phenotypes and Causes of Type 2 Diabetes in Children. [europepmc]
• Metabolomics of Type 1 and Type 2 Diabetes: Insights into Risk Prediction and Mechanisms. [europepmc]
• Coordination of glucose monitoring, self-care behaviour and mental health: achieving precision monitoring in diabetes. [europepmc]
• Algorithm-Enabled, Personalized Glucose Management for Type 1 Diabetes at the Population Scale: Prospective Evaluation in Clinical Practice. [europepmc]
• Precision prognostics for the development of complications in diabetes. [europepmc]
• The role of mental disorders in precision medicine for diabetes: a narrative review. [europepmc]
• Clinical variable-based cluster analysis identifies novel subgroups with a distinct genetic signature, lipidomic pattern and cardio-renal risks in Asian patients with recent-onset type 2 diabetes. [europepmc]
• An Insulin Receptor-Binding Multifunctional Protein from Tamarindus indica L. Presents a Hypoglycemic Effect in a Diet-Induced Type 2 Diabetes-Preclinical Study. [europepmc]
• Tirzepatide for the treatment of adults with type 2 diabetes: An endocrine perspective. [europepmc]
• Precision medicine in type 1 diabetes. [europepmc]
• Diabetes precision medicine: plenty of potential, pitfalls and perils but not yet ready for prime time. [europepmc]
• Time above range for predicting the development of type 2 diabetes. [europepmc]
• Precision medicine in complex diseases-Molecular subgrouping for improved prediction and treatment stratification. [europepmc]
• Diabetes and artificial intelligence beyond the closed loop: a review of the landscape, promise and challenges. [europepmc]
• Defining type 2 diabetes polygenic risk scores through colocalization and network-based clustering of metabolic trait genetic associations. [europepmc]
• Islet autoantibodies as precision diagnostic tools to characterize heterogeneity in type 1 diabetes: a systematic review. [europepmc]
• A global initiative to deliver precision health in diabetes. [europepmc]